Clinical Trial Update: Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of weekly topotecan with cisplatin in advanced or recurrent cervical cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Topotecan (topotecan)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cervix Cancer | Phase 1 | Status: TERMINATED